Latest Mesothelioma Researches

According to Science Daily, an online resource for latest research news, mesothelioma patients who got treated by a combination of 2 drugs had an improved chance of surviving. Their survival rate increased by a minimum of 3 months. The two drugs used for the treatment were PEMETREXED and CISPLATIN. The clinical trials were done on 448 mesotheliomic patients.About 80% of the mesotheliomic patients were men with an average age of 61 years. Some patients received only cisplatin whereas some patients received a combination of pemetrexed, cisplatin, vitamin supplements, folic acid and B12. Not only did their life span increase by three months but also the patients felt less tired, had improved appetite, experienced less pain and had smaller coughing spells. The clinical trial and research was done at the Clatterbridge Center for Oncology in England.

The Mesothelioma Researches 2 & 3 further elaborate on the medical advances made regarding pleural mesothelioma, peritoneal mesothelioma or pericardial mesothelioma.

Thank you